DSS, Inc. said it will not proceed with its previously announced proposed public offering of common stock after determining that limited capacity under its existing shelf registration statement prevented the transaction from moving forward. The company continues to evaluate capital-raising alternatives and said it remains focused on creating value for shareholders. DSS had previously said the offering would involve newly issued shares for general corporate and working capital needs, with Aegis Capital Corp. serving as sole book-running manager, but the release did not disclose the offering’s size, pricing or expected completion date. DSS’s common stock trades on NYSE American under the symbol DSS. The company operates across product packaging, biotechnology, commercial lending, and securities and investment management, and says it develops high-growth subsidiaries and seeks to unlock value through strategic IPOs and public listings.